Dash Pharmaceuticals Pvt Ltd - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Dash Pharmaceuticals Pvt Ltd

Dash Pharmaceuticals Pvt Ltd, a struck off private limited company, was established on 21 October 1985 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239MH1985PTC037818. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.

Its leadership includes Anthony Francis Lopes (Director), Dilip Ashok Kherade (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 109, Nikhil Heritage, Achole Road Nallasopara (East), Dist. Thane, Mumbai, Maharashtra, 401209.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1985PTC037818

  • Registration Number

    037818

  • Incorporation Date

    21 October 1985

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 40 Year, 7 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Dash Pharmaceuticals Pvt Ltd

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Dash Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dash Pharmaceuticals Pvt Ltd?
Current Directors
Name Designation Appointment Date Status
Anthony Francis Lopes Director 02 May 2002 Current
Dilip Ashok Kherade Director 03 Apr 2006 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dash Pharmaceuticals.

Enhance accessibility to Dash Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Dash Pharmaceuticals revenue growth over time
Dash Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dash Pharmaceuticals?

Unlock access to Dash Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dash Pharmaceuticals?

Unlock and access historical data on people associated with Dash Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dash Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dash Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dash Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Dash Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Dash Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Dilip Ashok Kherade was appointed as a Director was appointed as a Director on 03 Apr 2006 & has been associated with this company since 20 years 1 month . was completed.

  • Director Appointment

    Progress on Anthony Francis Lopes was appointed as a Director was appointed as a Director on 02 May 2002 & has been associated with this company since 24 years 28 days . was documented.

  • Company Incorporation

    Dash Pharmaceuticals Pvt Ltd was registered on 21 Oct 1985 with Roc Mumbai & aged 40 years 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dash Pharmaceuticals Pvt Ltd?

The CIN of Dash Pharmaceuticals Pvt Ltd is U24239MH1985PTC037818.

Where is Dash Pharmaceuticals Pvt Ltd headquartered?

Dash Pharmaceuticals Pvt Ltd is headquartered at 109, Nikhil Heritage, Achole Road Nallasopara (East), Dist. Thane, Mumbai, Maharashtra, 401209.

When was Dash Pharmaceuticals Pvt Ltd incorporated?

Dash Pharmaceuticals Pvt Ltd was incorporated on 21 October 1985.

Who are the current directors of Dash Pharmaceuticals Pvt Ltd?

The current directors of Dash Pharmaceuticals Pvt Ltd are

What is the primary industry of Dash Pharmaceuticals Pvt Ltd?

The primary industry of Dash Pharmaceuticals Pvt Ltd is Chemicals.

Is Dash Pharmaceuticals Pvt Ltd a listed company?

Dash Pharmaceuticals Pvt Ltd is unlisted.

What is the capital structure of Dash Pharmaceuticals Pvt Ltd?

The authorized capital of Dash Pharmaceuticals Pvt Ltd is ₹0.30 M, and the paid-up capital is ₹0.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available